Received Feb 3, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | Y016291 | SYR / LA |
Patient developed redness, swelling of left arm with rash and fever day after vaccine was administered. It got worse and was brought to ER on 01-30-2026. He was transferred to another hospital and was admitted on 01-31-2026. He received IV fluids and IV clindamycin. The swelling and redness improved but not completely. He was discharged on 02-02-2026 to continue oral clindamycin for 5 more days. He has not followed yet since he was discharged yesterday
He developed swelling and redness to the left deltoid area day he got the Pneumovax (given on 01-29-2026). He had URI symptoms on the day he was seen at the first hospital. He was transferred to a second hospital. While in ER, he had nausea and vomiting. Rapid tests were negative for Flu, COVID. Respiratory panel (PCR) was positive for parainfluenza.
none
CETIRIZINE (1MG/ML) 5 ML AT BEDTIME PO; CLONIDINE 0.2 MG 1 TABLET AT BEDTIME PO; QUILLIVANT XR (25 MG/5 ML) 8 ML IN AM PO
NONE
Leukocytosis (WBC 18,800 with bandemia at the first hospital; 23,600 at the second hospital. Prior to discharge, WBC went down to 16,000. Respiratory panel was positive for parainfluenza virus 2